In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Mar-31-17 | Mar-31-16 | Mar-31-15 | Mar-31-14 |
| 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F |
Revenues: |
Maximum | 151.7 | | | | | | | |
Other Educational Services | 21.2 | 20.0 | 9.0 | | | | | |
Others | | 3.4 | 6.3 | 1.3 | | | | |
Overseas Art Study Services | 181.0 | 138.7 | 82.4 | | | | | |
Total revenues | 202.2 | 162.2 | 97.8 | 1.3 | 8.8 | 417.1 | 350.2 | 384.7 |
Revenue growth [+] | 24.7% | 65.9% | 7204.0% | | -97.9% | 19.1% | -9.0% | 4.9% |
Other Educational Services | 5.7% | 121.4% | | | | | | |
Others | | -45.8% | 374.2% | | | | | |
Overseas Art Study Services | 30.5% | 68.4% | | | | | | |
Cost of goods sold | 97.4 | 98.5 | 61.9 | 4.3 | 4.4 | 208.0 | 172.5 | 188.5 |
Gross profit | 104.8 | 63.6 | 35.9 | -2.9 | 4.4 | 209.1 | 177.6 | 196.2 |
Gross margin | 51.8% | 39.2% | 36.7% | -217.6% | 50.1% | 50.1% | 50.7% | 51.0% |
Selling, general and administrative [+] | 159.4 | 153.6 | 116.0 | 49.1 | 41.3 | 121.0 | 109.9 | 118.9 |
Sales and marketing | 66.1 | 53.5 | 34.1 | 5.6 | 5.2 | 42.6 | 45.2 | 47.3 |
General and administrative | 93.3 | 100.1 | 81.9 | 43.5 | 36.1 | 78.3 | 64.8 | 71.6 |
Research and development | 11.8 | 8.8 | 11.8 | 19.6 | 19.9 | 36.5 | 36.8 | 27.7 |
Equity in earnings | | | | | -2.8 | -8.8 | -2.2 | |
Other operating expenses | 0.0 | 8.7 | 25.8 | -3.8 | | -0.1 | -1.2 | -4.8 |
EBITDA [+] | -43.4 | -77.6 | -100.2 | -54.5 | -49.3 | 51.5 | 37.5 | 65.2 |
EBITDA growth | -44.1% | -22.6% | 84.0% | | -195.8% | 37.5% | -42.6% | 73.3% |
EBITDA margin | -21.4% | -47.8% | -102.5% | -4068.5% | -558.8% | 12.4% | 10.7% | 17.0% |
Depreciation | 5.8 | 8.0 | 5.2 | 11.3 | 10.1 | 8.4 | 7.4 | 8.4 |
EBITA | -49.2 | -85.6 | -105.4 | -65.8 | -59.4 | 43.1 | 30.1 | 56.8 |
EBITA margin | -24.3% | -52.8% | -107.8% | -4914.1% | -673.0% | 10.3% | 8.6% | 14.8% |
Amortization of intangibles | 17.2 | 21.9 | 12.4 | 2.0 | 0.2 | 0.2 | 0.2 | 2.4 |
EBIT [+] | -66.4 | -107.5 | -117.8 | -67.8 | -59.6 | 42.9 | 29.9 | 54.5 |
EBIT growth | -38.2% | -8.7% | 73.7% | | -239.0% | 43.6% | -45.1% | 101.6% |
EBIT margin | -32.8% | -66.3% | -120.5% | -5064.4% | -675.3% | 10.3% | 8.5% | 14.2% |
Non-recurring items [+] | | | | | | | 0.3 | 12.0 |
Asset impairment | | | | | | | 0.3 | 12.0 |
Interest income | 1.1 | 1.2 | 3.3 | 2.4 | 1.5 | 3.6 | 4.1 | 4.8 |
Interest income | 1.1 | 1.2 | 3.3 | 2.4 | 1.5 | 3.6 | 4.1 | 4.8 |
Other income (expense), net [+] | 27.3 | -4.5 | -26.8 | -2.7 | -0.1 | -1.5 | -1.1 | 0.0 |
Impairment of investments | -6.0 | -1.7 | -26.8 | -6.4 | | | | |
Gain (loss) on foreign currency transactions | -0.2 | -1.1 | 0.1 | 1.0 | -0.1 | -1.5 | -1.1 | 0.0 |
Other | 28.4 | -3.4 | -23.5 | -0.3 | | | | 4.7 |
Pre-tax income | -37.9 | -110.9 | -141.3 | -68.1 | -58.2 | 45.0 | 32.6 | 47.2 |
Income taxes | -1.5 | -10.3 | -7.1 | -923.0 | 1.5 | 18.9 | 9.6 | 19.9 |
Tax rate | 4.1% | 9.3% | 5.1% | 1356.3% | | 42.1% | 29.3% | 42.2% |
Earnings from continuing ops | -36.4 | -100.6 | -268.2 | -1,005.7 | -119.5 | 26.1 | 23.1 | 26.8 |
Earnings from discontinued ops | | | 4.9 | 1,856.3 | 49.8 | | | |
Net income | -36.4 | -100.6 | -263.3 | 850.6 | -69.7 | 26.1 | 23.1 | 26.8 |
Net margin | -18.0% | -62.0% | -269.3% | 63544.5% | -789.3% | 6.2% | 6.6% | 7.0% |
|
Basic EPS [+] | ($0.58) | ($1.61) | ($5.27) | ($21.96) | ($2.61) | $0.57 | $0.51 | $0.59 |
Growth | -63.9% | -69.5% | -76.0% | | -557.3% | 12.9% | -14.6% | 17.7% |
Diluted EPS [+] | ($0.58) | ($1.61) | ($5.27) | ($21.96) | ($2.61) | $0.57 | $0.51 | $0.59 |
Growth | -63.9% | -69.5% | -76.0% | | -557.3% | 12.9% | -14.6% | 17.7% |
|
Dividends per share [+] | | | | $20.67 | | | $1.28 | |
Growth | | | -100.0% | | | -100.0% | | -100.0% |
|
Shares outstanding (basic) [+] | 62.7 | 62.7 | 50.9 | 45.8 | 45.8 | 45.6 | 45.6 | 45.2 |
Growth | 0.1% | 23.1% | 11.2% | | 0.3% | 0.1% | 0.8% | 0.3% |
Shares outstanding (diluted) [+] | 62.7 | 62.7 | 50.9 | 45.8 | 45.8 | 45.6 | 45.6 | 45.2 |
Growth | 0.1% | 23.1% | 11.2% | | 0.3% | 0.1% | 0.8% | 0.3% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |